top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
THC961
Thyroid cancer tissue array, set 1, non-overlapping with THC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$298
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Thyroid carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Tumor 1 cm or less in greatest dimension, limited to the thyroid
T2 - Tumor more than 1 cm but not more than 4 cm in greatest dimension, limited to the thyroid
T3 - Tumor more than 4 cm in greatest dimension, limited to the thyroid
T4 - Tumor of any size extending beyond the thyroid capsule
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
N1a - Metastasis in ipsilateral cervical lymph nodes
N1b - Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph nodes
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Histopathologic Types
- Papillary carcinoma
- Follicular carcinoma
- Medullary carcinoma
- Undifferentiated (anaplastic) carcinoma
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of thyroid cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 48 | Thyroid | Normal | |||
A02 | F | 43 | Thyroid | Normal | |||
A03 | F | 43 | Thyroid | Normal | |||
A04 | F | 51 | Thyroid | Subacute thyroiditis | |||
A05 | F | 57 | Thyroid | Adenoma, fetal type | |||
A06 | F | 50 | Thyroid | Hashimoto's thyroiditis | |||
A07 | F | 50 | Thyroid | Multi-nodular goiter | |||
A08 | F | 53 | Thyroid | Multi-nodular goiter | |||
A09 | M | 63 | Thyroid | Multi-nodular goiter | |||
A10 | F | 41 | Thyroid | Multi-nodular goiter | |||
A11 | F | 40 | Thyroid | Adenoma | |||
A12 | M | 28 | Thyroid | Follicular adenoma | |||
B01 | F | 48 | Thyroid | Normal | |||
B02 | F | 43 | Thyroid | Normal | |||
B03 | F | 43 | Thyroid | Normal | |||
B04 | F | 51 | Thyroid | Subacute thyroiditis | |||
B05 | F | 57 | Thyroid | Adenoma, fetal type | |||
B06 | F | 50 | Thyroid | Hashimoto's thyroiditis | |||
B07 | F | 50 | Thyroid | Multi-nodular goiter | |||
B08 | F | 53 | Thyroid | Multi-nodular goiter | |||
B09 | M | 63 | Thyroid | Multi-nodular goiter | |||
B10 | F | 41 | Thyroid | Multi-nodular goiter | |||
B11 | F | 40 | Thyroid | Adenoma | |||
B12 | M | 28 | Thyroid | Follicular adenoma | |||
C01 | F | 33 | Thyroid | Adenoma, fetal type | |||
C02 | M | 44 | Thyroid | Simple colloid adenoma | |||
C03 | F | 56 | Thyroid | Graves' disease | |||
C04 | F | 27 | Thyroid | Hashimoto's thyroiditis | |||
C05 | F | 18 | Thyroid | Graves' disease | |||
C06 | F | 53 | Thyroid | Hashimoto's thyroiditis | |||
C07 | F | 24 | Thyroid | Papillary adenocarcinoma | II~III | T2N1M0 | |
C08 | M | 50 | Thyroid | Papillary adenocarcinoma | I~II | T2N0M0 | |
C09 | M | 57 | Thyroid | Papillary adenocarcinoma | T4N1M0 | ||
C10 | F | 27 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
C11 | M | 52 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
C12 | F | 19 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
D01 | F | 33 | Thyroid | Adenoma, fetal type | |||
D02 | M | 44 | Thyroid | Simple colloid adenoma | |||
D03 | F | 56 | Thyroid | Graves' disease | |||
D04 | F | 27 | Thyroid | Hashimoto's thyroiditis | |||
D05 | F | 18 | Thyroid | Graves' disease | |||
D06 | F | 53 | Thyroid | Hashimoto's thyroiditis | |||
D07 | F | 24 | Thyroid | Papillary adenocarcinoma | II~III | T2N1M0 | |
D08 | M | 50 | Thyroid | Papillary adenocarcinoma | I~II | T2N0M0 | |
D09 | M | 57 | Thyroid | Papillary adenocarcinoma | T4N1M0 | ||
D10 | F | 27 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
D11 | M | 52 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
D12 | F | 19 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
E01 | F | 31 | Thyroid | Papillary adenocarcinoma | III | T3N0M0 | |
E02 | M | 16 | Thyroid | Follicular carcinoma | T3N1M0 | ||
E03 | F | 33 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E04 | M | 34 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
E05 | F | 44 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E06 | F | 42 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E07 | F | 64 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
E08 | M | 51 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
E09 | F | 22 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E10 | F | 30 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
E11 | F | 38 | Thyroid | Papillary adenocarcinoma | T3N0M0 | ||
E12 | F | 11 | Thyroid | Papillary adenocarcinoma | T3N1M0 | ||
F01 | F | 31 | Thyroid | Papillary adenocarcinoma | III | T3N0M0 | |
F02 | M | 16 | Thyroid | Follicular carcinoma | T3N1M0 | ||
F03 | F | 33 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F04 | M | 34 | Thyroid | Follicular papillary adenocarcinoma | T2N1M0 | ||
F05 | F | 44 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F06 | F | 42 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F07 | F | 64 | Thyroid | Papillary adenocarcinoma | T2N1M0 | ||
F08 | M | 51 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
F09 | F | 22 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F10 | F | 30 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
F11 | F | 38 | Thyroid | Papillary adenocarcinoma | T3N0M0 | ||
F12 | F | 11 | Thyroid | Papillary adenocarcinoma | T3N1M0 | ||
G01 | M | 58 | Thyroid | Papillary adenocarcinoma | T3N0M1 | ||
G02 | M | 19 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G03 | M | 58 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
G04 | F | 41 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G05 | M | 26 | Thyroid | Follicular carcinoma | T2N1M0 | ||
G06 | F | 44 | Thyroid | Follicular carcinoma | T2N0M0 | ||
G07 | F | 54 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
G08 | M | 65 | Thyroid | Undifferentiated carcinoma | T3N0M0 | ||
G09 | F | 79 | Thyroid | Undifferentiated carcinoma | T3N1M0 | ||
G10 | M | 63 | Thyroid | Medullary carcinoma | T2N1M0 | ||
G11 | F | 25 | Thyroid | Lymphoma, diffuse large B cell lymphoma | |||
G12 | F | 77 | Thyroid | Lymphoma, MALT-B cell lymphoma, high grade | |||
H01 | M | 58 | Thyroid | Papillary adenocarcinoma | T3N0M1 | ||
H02 | M | 19 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H03 | M | 58 | Thyroid | Papillary adenocarcinoma | T1N0M0 | ||
H04 | F | 41 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H05 | M | 26 | Thyroid | Follicular carcinoma | T2N1M0 | ||
H06 | F | 44 | Thyroid | Follicular carcinoma | T2N0M0 | ||
H07 | F | 54 | Thyroid | Papillary adenocarcinoma | T2N0M0 | ||
H08 | M | 65 | Thyroid | Undifferentiated carcinoma | T3N0M0 | ||
H09 | F | 79 | Thyroid | Undifferentiated carcinoma | T3N1M0 | ||
H10 | M | 63 | Thyroid | Medullary carcinoma | T2N1M0 | ||
H11 | F | 25 | Thyroid | Lymphoma, diffuse large B cell lymphoma | |||
H12 | F | 77 | Thyroid | Lymphoma, MALT-B cell lymphoma, high grade | |||
null |
bottom of page